From Medscape Diabetes & Endocrinology

Coverage from the

American Diabetes Association (ADA) 78th Scientific Sessions

June 22 - 26, 2018; Orlando, Florida

June 22 - 26, 2018 Orlando, Florida

ADA 2018 Asian Indians Up Diabetes Risk by Adopting Poor Lifestyle Providing culturally friendly diet, education, and physical activity programs may promote lifestyle changes and prevent diabetes in this high-risk group of Asian Indian Americans, say researchers.
Medscape Medical News, July 13, 2018
ADA 2018 TEDDY: More Small Clues to the Pathogenesis of Type 1 Diabetes Latest TEDDY findings point to childhood infections, in particular gastrointestinal infections, as drivers of islet autoimmunity subtypes in the pathogenesis of type 1 diabetes.
Medscape Medical News, July 9, 2018
ADA 2018 Liraglutide: A New Player in Type 1 Diabetes Treatment? In a randomized, placebo-controlled trial, liraglutide added to insulin improved glycemic control and reduced weight and blood pressure.
Medscape Medical News, July 9, 2018

Meeting Highlights At A Glance

Top News From ADA 2018: Slideshow New trial results in type 1 and type 2 diabetes and glucose-sensing technology featured prominently at this year's meeting.

Conference News

ADA 2018 Asian Indians Up Diabetes Risk by Adopting Poor Lifestyle
Medscape Medical News, July 13, 2018
ADA 2018 TEDDY: More Small Clues to the Pathogenesis of Type 1 Diabetes
Medscape Medical News, July 9, 2018
ADA 2018 Liraglutide: A New Player in Type 1 Diabetes Treatment?
Medscape Medical News, July 9, 2018
ADA 2018 Long-Term Testosterone Reverses Diabetes in Some Hypogonadal Men
Medscape Medical News, July 5, 2018
ADA 2018 Investigational Tube-Free Pump for U-500 Insulin: A Viable Option
Medscape Medical News, July 5, 2018
ADA 2018 Very High HbA1c Falls Most With GLP-1 Agonist Plus Basal Insulin
Medscape Medical News, July 4, 2018
ADA 2018 Flash Continuous-Glucose-Monitoring System Shows Real-World Benefits
Reuters Health Information, July 3, 2018
ADA 2018 Does the Pill Raise Risk for Diabetes After Menopause?
Medscape Medical News, July 3, 2018
ADA 2018 Insomnia a Risk Factor for Type 2 Diabetes
Reuters Health Information, July 2, 2018
ADA 2018 PIONEER: First Phase 3 Data on Oral Semaglutide in Diabetes
Medscape Medical News, July 2, 2018
ADA 2018 New ADA/EASD Guidance on Diabetes: Assess CV Status First
Medscape Medical News, June 29, 2018
ADA 2018 VADT at 15 Years: No Legacy Effect From Intensive HbA1c Control
Medscape Medical News, June 28, 2018
ADA 2018 Artificial Pancreas Helps Inpatients With Type 2 Diabetes
Medscape Medical News, June 27, 2018
ADA 2018 Youth-Onset Diabetes Needs Different Approach to That in Adults
Medscape Medical News, June 27, 2018

ADA 2018 SGLT Inhibitors Explored as Type 1 Diabetes Treatment
Medscape Medical News, June 26, 2018
ADA 2018 PCSK9 Inhibitors More Cost-Effective in Diabetes Patients?
Medscape Medical News, June 26, 2018
ADA 2018 ACC/AHA's BP Goals Up Primary Care Workload, More So in Diabetes
Medscape Medical News, June 25, 2018
ADA 2018 Real-World Test of Sugar.IQ App Encouraging in Diabetes
Medscape Medical News, June 25, 2018
ADA 2018 New Study Finds No Link Between Canagliflozin and Amputations
Medscape Medical News, June 25, 2018
ADA 2018 Type 1 Diabetes in Pregnancy Doubles Risk for Autism in Offspring
Medscape Medical News, June 25, 2018
ADA 2018 'Clinical Inertia' Common in Uncontrolled Diabetes Patients
Medscape Medical News, June 24, 2018
ADA 2018 Novel Systems Could Expand 'Hybrid Closed-Loop' Field in Diabetes
Medscape Medical News, June 24, 2018
ADA 2018 Human Insulin Could Be Front-Line for Many With Type 2 Diabetes
Medscape Medical News, June 24, 2018
ADA 2018 Cost Issues Prevent a Quarter of Patients From Taking Insulin
Medscape Medical News, June 23, 2018
ADA 2018 Implantable Glucose Sensor Bests Competitors in Head-to-Head
Medscape Medical News, June 23, 2018
ADA 2018 Love Affair With Metformin: Still Strong, or Time to Move On?
Medscape Medical News, June 23, 2018
ADA 2018 Technology Themes Will Be Center Stage at ADA in Orlando
Medscape Medical News, June 14, 2018

Popular News from ADA 2017

CANVAS: Experts Spar on Canagliflozin Risk/Benefit in Diabetes Some see the newly revealed cardiovascular benefits as rendering canagliflozin essentially "interchangeable" with empagliflozin, while others view the amputation signal as a deal breaker.
Medscape Medical News, Jun 16, 2017
CV-Outcomes Trials in Diabetes Must Drive Guideline Change On the eve of the results of another large CV-outcomes trial with a type 2 diabetes drug, Steve Nissen told the ADA meeting why these studies are so important and must drive change in clinical practice.
Medscape Medical News, Jun 12, 2017
A Perfect Twitter Storm: Why Is the ADA So Anti-Social Media? A big row has erupted on Twitter at the ADA meeting, where organizers are politely requesting that users delete tweets containing pictures of slides. Many refused and called on the ADA to change this policy.
Medscape Medical News, Jun 11, 2017
DEVOTE: Tresiba as Safe as Glargine With Less Severe Hypoglycemia The number needed to treat with insulin degludec rather than glargine to prevent one episode of severe hypoglycemia is 40.
Medscape Medical News, Jun 12, 2017
SGLT1/2 Inhibitor Sotagliflozin 'Encouraging' in Type 1 Diabetes The investigational, oral agent sotagliflozin, a first-in-class, oral dual inhibitor of both SGLT1 and SGLT2, is in phase 3 trials in type 1 diabetes; results are promising but there are some caveats.
Medscape Medical News, Jun 22, 2017